Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-28

Clinical Trial Update: Vitamin B12 Supplement to Prevent Cognitive Decline [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a Vitamin B12 supplement to prevent cognitive decline has completed. The study was sponsored by the Chinese University of Hong…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin B12 supplement (Cobalamin)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Cognitive Decline | Phase 4 | Status: COMPLETED